{
    "2018-09-27": [
        [
            {
                "time": "",
                "original_text": "投资人视角|生物类似药新政发布，一致性评价势在必行",
                "features": {
                    "keywords": [
                        "生物类似药",
                        "新政",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-09-27",
                "original_text": "09月27日 主力资金近三日都在买这些概念股",
                "features": {
                    "keywords": [
                        "主力资金",
                        "概念",
                        "买入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药股集体大涨 机构揭秘打好四季度“反击战”的三条思路",
                "features": {
                    "keywords": [
                        "医药股",
                        "大涨",
                        "机构",
                        "四季度",
                        "反击战"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业向来是一片创新研发“沃土” 医药板块未来可期",
                "features": {
                    "keywords": [
                        "医药行业",
                        "创新研发",
                        "未来可期"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "大涨10%！上证50创下最牛阶段表现，股债大轮动？",
                "features": {
                    "keywords": [
                        "大涨",
                        "上证50",
                        "股债轮动"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "指数"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "浙江公布“两票制”视同生产企业等名单调整信息",
                "features": {
                    "keywords": [
                        "浙江",
                        "两票制",
                        "生产企业",
                        "名单调整"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药创新再迎政策激励 7只低估值业绩预喜股潜力足",
                "features": {
                    "keywords": [
                        "医药创新",
                        "政策激励",
                        "低估值",
                        "业绩预喜"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}